171 related articles for article (PubMed ID: 2785520)
21. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF.
Kurachi H; Morishige K; Adachi H; Adachi K; Tasaka K; Sawada M; Miyake A
Cancer; 1994 Dec; 74(11):2984-90. PubMed ID: 7954262
[TBL] [Abstract][Full Text] [Related]
22. Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies.
Falette N; Lefebvre MF; Meggouh F; Eynard M; Garin E; Saez S
Breast Cancer Res Treat; 1992 Mar; 20(3):177-83. PubMed ID: 1571570
[TBL] [Abstract][Full Text] [Related]
23. Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.
Fujiwara S; Nawa A; Nakanishi T; Shimoyama Y; Kajiyama H; Shibata K; Ino K; Nakamura S; Kikkawa F; Yatabe Y
Hum Pathol; 2010 Apr; 41(4):560-5. PubMed ID: 20004952
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
25. Oncogene and growth factor expression in ovarian cancer.
Kommoss F; Bauknecht T; Birmelin G; Kohler M; Tesch H; Pfleiderer A
Acta Obstet Gynecol Scand Suppl; 1992; 155():19-24. PubMed ID: 1502888
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of EGF-R and TGFa in human ovarian carcinomas.
Bauknecht T; Kommoss F; Birmelin G; von Kleist S; Kohler M; Pfleiderer A
Anticancer Res; 1991; 11(4):1523-8. PubMed ID: 1746909
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas.
Kato K; Ueoka Y; Kato K; Tamura T; Nishida J; Wake N
Eur J Cancer; 1998 Apr; 34(5):737-44. PubMed ID: 9713283
[TBL] [Abstract][Full Text] [Related]
28. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
29. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium.
Imai T; Kurachi H; Adachi K; Adachi H; Yoshimoto Y; Homma H; Tadokoro C; Takeda S; Yamaguchi M; Sakata M
Biol Reprod; 1995 Apr; 52(4):928-38. PubMed ID: 7540053
[TBL] [Abstract][Full Text] [Related]
30. Characterization of transforming growth factor-alpha receptors in the avian ovary: alterations in ligand binding to granulosa cells during follicular maturation.
Onagbesan OM; Woolveridge I; Peddie MJ
J Endocrinol; 1996 Apr; 149(1):171-9. PubMed ID: 8676049
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor and its receptors in human pancreatic carcinoma.
Chen YF; Pan GZ; Hou X; Liu TH; Chen J; Yanaihara C; Yanaihara N
Pancreas; 1990 May; 5(3):278-83. PubMed ID: 2343041
[TBL] [Abstract][Full Text] [Related]
32. Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.
Perroteau I; Salomon D; DeBortoli M; Kidwell W; Hazarika P; Pardue R; Dedman J; Tam J
Breast Cancer Res Treat; 1986; 7(3):201-10. PubMed ID: 3465381
[TBL] [Abstract][Full Text] [Related]
33. Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus.
Pfeiffer D; Kimmig R; Herrmann J; Ruge M; Fisseler-Eckhoff A; Scheidel P; Jensen A; Schatz H; Pfeiffer A
Int J Cancer; 1998 Feb; 79(1):49-55. PubMed ID: 9495358
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas.
Bauknecht T; Runge M; Schwall M; Pfleiderer A
Gynecol Oncol; 1988 Feb; 29(2):147-57. PubMed ID: 3338667
[TBL] [Abstract][Full Text] [Related]
35. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
Ray A; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
[TBL] [Abstract][Full Text] [Related]
36. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of estradiol, epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor in endometrial neoplasia.
Yokoyama Y; Takahashi Y; Hashimoto M; Morishita S; Tamaya T
Jpn J Clin Oncol; 1996 Dec; 26(6):411-6. PubMed ID: 9001345
[TBL] [Abstract][Full Text] [Related]
38. Expression of epidermal growth factor receptors in human endometrial carcinoma.
Nyholm HC; Nielsen AL; Ottesen B
Int J Gynecol Pathol; 1993 Jul; 12(3):241-5. PubMed ID: 8344761
[TBL] [Abstract][Full Text] [Related]
39. Cellular binding proteins for vitamin A in human carcinomas and in normal tissues.
Palan PR; Romney SL
Cancer Res; 1980 Nov; 40(11):4221-4. PubMed ID: 6258773
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor-like proteins in breast fluid and human milk.
Connolly JM; Rose DP
Life Sci; 1988; 42(18):1751-6. PubMed ID: 3258952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
